Surgimab raised €6.6M in a funding round in Feb 2018. The company is based in France. Investors in the round: Abalis Finance, Cathey World Investment. Data as of 27 Sept 2026.
Reported in EUR — no conversion. €6.6M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
